Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Sensus Healthcare, Inc. (SRTS : NSDQ)
 
 • Company Description   
Sensus Healthcare, Inc. is a medical device company It specializes in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy. The company's portfolio of treatment devices consists of the SRT-100(TM) and SRT-100 Vision(TM). Sensus Healthcare, Inc. is headquartered in Boca Raton, Florida.

Number of Employees: 37

 
 • Price / Volume Information   
Yesterday's Closing Price: $8.97 Daily Weekly Monthly
20 Day Moving Average: 249,257 shares
Shares Outstanding: 16.68 (millions)
Market Capitalization: $149.60 (millions)
Beta: 0.52
52 Week High: $11.96
52 Week Low: $3.08
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 2.05% 11.40%
12 Week -14.49% -7.58%
Year To Date 24.24% 47.16%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
851 BROKEN SOUND PARKWAY NW SUITE 215
-
BOCA RATON,FL 33487
USA		 ph: 561-922-5808
fax: 561-948-2071		 kgolodetz@lhai.com http://www.sensushealthcare.com
 
 • General Corporate Information   
Officers
Joseph Sardano - Chief Executive Officer and Chairman
Javier Rampolla - Chief Financial Officer
Megan Cornish - Director
John Heinrich - Director
William H. McCall - Director

Peer Information
Sensus Healthcare, Inc. (ABMD)
Sensus Healthcare, Inc. (DMDS)
Sensus Healthcare, Inc. (CPWY.)
Sensus Healthcare, Inc. (EQUR)
Sensus Healthcare, Inc. (ECIA)
Sensus Healthcare, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 81728J109
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/04/22
Share - Related Items
Shares Outstanding: 16.68
Most Recent Split Date: (:1)
Beta: 0.52
Market Capitalization: $149.60 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.18 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.76 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/04/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 11.80
Trailing 12 Months: 17.59
PEG Ratio: -
Price Ratios
Price/Book: 3.52
Price/Cash Flow: 31.50
Price / Sales: 4.36
EPS Growth
vs. Year Ago Period: 385.71%
vs. Previous Quarter: -37.50%
Sales Growth
vs. Year Ago Period: 236.74%
vs. Previous Quarter: -20.63%
ROE
03/31/22 - 31.17
12/31/21 - 18.88
09/30/21 - -0.87
ROA
03/31/22 - 24.66
12/31/21 - 14.88
09/30/21 - -0.68
Current Ratio
03/31/22 - 4.72
12/31/21 - 5.24
09/30/21 - 5.13
Quick Ratio
03/31/22 - 4.50
12/31/21 - 4.94
09/30/21 - 4.70
Operating Margin
03/31/22 - 24.82
12/31/21 - 15.23
09/30/21 - -0.95
Net Margin
03/31/22 - 62.07
12/31/21 - 15.23
09/30/21 - -0.95
Pre-Tax Margin
03/31/22 - 63.96
12/31/21 - 15.23
09/30/21 - -0.95
Book Value
03/31/22 - 2.55
12/31/21 - 1.57
09/30/21 - 1.24
Inventory Turnover
03/31/22 - 5.08
12/31/21 - 3.58
09/30/21 - 2.23
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©